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Abstract
Despite the substantial burden of hypertension in US minority populations, few genetic
studies of blood pressure have been conducted in Hispanics and African Americans, and it
is unclear whether many of the established loci identified in European-descent populations
contribute to blood pressure variation in non-European descent populations. Using the
Metabochip array, we sought to characterize the genetic architecture of previously identi-
fied blood pressure loci, and identify novel cardiometabolic variants related to systolic and
diastolic blood pressure in a multi-ethnic US population including Hispanics (n = 19,706)
and African Americans (n = 18,744). Several known blood pressure loci replicated in Afri-
can Americans and Hispanics. Fourteen variants in three loci (KCNK3, FGF5, ATXN2-
SH2B3) were significantly associated with blood pressure in Hispanics. The most
PLOS ONE | DOI:10.1371/journal.pone.0164132 October 13, 2016 1 / 12
a11111
OPENACCESS
Citation: Franceschini N, Carty CL, Lu Y, Tao R,
Sung YJ, Manichaikul A, et al. (2016) Variant
Discovery and Fine Mapping of Genetic Loci
Associated with Blood Pressure Traits in Hispanics
and African Americans. PLoS ONE 11(10):
e0164132. doi:10.1371/journal.pone.0164132
Editor: Randall Lee Rasmusson, University at
Buffalo—The State University of New York,
UNITED STATES
Received: March 27, 2016
Accepted: September 12, 2016
Published: October 13, 2016
Copyright: This is an open access article, free of all
copyright, and may be freely reproduced,
distributed, transmitted, modified, built upon, or
otherwise used by anyone for any lawful purpose.
The work is made available under the Creative
Commons CC0 public domain dedication.
Data Availability Statement: Data files for the
individual PAGE studies included in these analyses
(ARIC, CARDIA, HCHS/SOL, IPM BioMe Biobank
and WHI) have been submitted to dbGaP (https://
www.ncbi.nlm.nih.gov/gap). Links for the
individual studies and phs numbers for the PAGE





significant diastolic blood pressure variant identified in our analysis, rs2586886/KCNK3
(P = 5.2 x 10−9), also replicated in independent Hispanic and European-descent samples.
African American and trans-ethnic meta-analysis data identified novel variants in the
FGF5, ULK4 and HOXA-EVX1 loci, which have not been previously associated with blood
pressure traits. Our identification and independent replication of variants in KCNK3, a gene
implicated in primary hyperaldosteronism, as well as a variant in HOTTIP (HOXA-EVX1)
suggest that further work to clarify the roles of these genes may be warranted. Overall, our
findings suggest that loci identified in European descent populations also contribute to blood
pressure variation in diverse populations including Hispanics and African Americans—popu-
lations that are understudied for hypertension genetic risk factors.
Introduction
Blood pressure (BP) is an important predictor of health [1, 2], and has a lifetime impact on the
risk of coronary heart disease, stroke, and kidney disease, which are conditions that dispropor-
tionately burden minority populations including Hispanic and African Americans [3]. The
heritability of BP ranges from 30% to 55% [4–6]. Despite this moderate genetic contribution
and the identification of a substantial number of genetic variants associated with BP traits, the
vast majority of the heritability remains unexplained [6]. Genome-wide association studies
(GWAS) have reported over 50 loci influencing BP and hypertension risk [7–12]. Most of these
loci were identified in individuals of European ancestry [7–9]. Studies of East Asians [10, 13]
and individuals with African ancestry [14, 15] have provided evidence for additional loci for
BP, even though sample sizes were smaller than in studies of European ancestry individuals.
Hispanics are the largest growingminority in the US. Even though the prevalence of hyper-
tension in this population is increasing, Hispanics are less likely to be aware of their high BP or
seek treatment for hypertension [16, 17]. This racial/ethnic subgroup has also been underrepre-
sented in GWAS of BP. Both Hispanic and African Americans are admixed populations and
the allele frequency of variants and linkage disequilibrium (LD) patterns vary depending on
the ancestral background of any individual. However, this diversity in genetic architecture can
expedite the discovery of risk variants, as exemplified in a recent study that identify the
SLC16A11 locus associated with type 2 diabetes risk in Hispanics only [18].
Using the Metabochip array, we characterized and fine-mapped previously reported BP loci
in a large multi-ethnic population.We also performed an array-wide analysis to identify novel
cardiometabolic genetic variants (available on the Metabochip) associated with BP traits in
Hispanic and AfricanAmericans. This study was performed as part of the Population Architec-
ture using Genomics and Epidemiology (PAGE) Consortium [19] which was funded by the




This study includes self-reportedHispanic and African American adults with genotyped or
imputed Metabochip genetic variants from the Population Architecture using Genomics and
Epidemiology (PAGE) Study [19] cohorts and the Family Blood Pressure Program (FBPP)
[20]. Samples from the Multi-Ethnic Study of Atherosclerosis (MESA) were used for
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To generalize novel findings to individuals of European ancestry, we used summary data
from the HapMap II meta-analysis of the International Consortiumof Blood Pressure (ICBP),
which included a discovery sample of 69,395 European-descent individuals [9]. Summary sta-
tistics frommeta-analyses are publicly available and were downloaded from http://www.ncbi.
nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000585.v1.p1
Genotyping and Outcomes
The Metabochip array design includes approximately 200,000 single nucleotide polymor-
phisms (SNPs) selected from GWAS loci as well as dense genotyping for fine-mapping of loci,
as previously described [21]. Genotyping on PAGE samples was performedwithin PAGE [22].
Descriptions of the FBPP and replication study genotyping are summarized in the Methods A
in S1 File. Standard QC filters were applied for samples and SNPs in PAGE: SNPs with call
rates<95%,>2 replication errors, Hardy-Weinberg Equilibrium p-value<1 x 10−6, Illumina
GenTrain Scores<0.6, Illumina Cluster Separation Scores<0.4 or discordant calls as specified
in [22] were excluded. A subset of WHI African Americans had genome-wide data available
from the SHARe GWAS; Metabochip genotypes were imputed in this sample, as described in
Liu et al. [23]. Imputed genotypes with rsq<0.30 were excluded from analyses. Ancestry princi-
pal components were determined using Eigensoft software separately for each study [24].
Ancestry outliers and first-degree relatives were excluded for PAGE studies except for SOL,
which adjusted for first degree relatives. Mt. Sinai BioMe used genotypes from the Illumina
HumanOmniExpress chip, which were imputed to 1000 Genome (1000G) Phase I integrated
haplotype panels (March 2012) using IMPUTE2. Only SNPs with imputation quality> 0.4 and
available on the Metabochip were examined in Mt. Sinai BioMe.
All studies, except Mt. Sinai BioMe, have standardizedmeasures of BP, including sitting sys-
tolic and diastolic BP measured by trained personnel, according to a standardized protocol that
specified a rest period of 5 minutes prior to measurement, bias-free instrumentation and
timed, repeat measurements (Methods A in S1 File). Mt. Sinai BioMe BP measures were
extracted from electronicmedical records (EMR). Hypertension was defined by a systolic
BP> 140 and diastolic BP> 90 mmHg or use of anti-hypertensive medication [25]. To cor-
rect for treatment effects, we added constants of 10 and 5 mmHg to the systolic BP and dia-
stolic BP, respectively, for individuals taking a BP lowering medication [7].
Statistical analysis
Each study prepared race/ethnicity-specificsummarymodels. Genotypes were coded using
additive genetic models, or allelic dosage for imputed SNPs. For studies of unrelated individu-
als, we used linear regression models to test associations of genotypes with quantitative BP
traits. For the studies that included related family members, we usedmethods to account for
the correlation structure due to genetic relatedness. Specifically, in the FBPP studies, we used
variance component models for quantitative traits and liability models for hypertension to
account for the family-based study design. The HCHS/SOL has approximately 2000 related
individuals, and a complex sampling design was used for recruitment. Therefore, we used the
W-PS method proposed by Lin et al, which is a weighted version of generalized estimation
equations, to account for unequal inclusion probabilities and family relationships[26]. All of
these models were adjusted for age, sex (except WHI), bodymass index (BMI) and principal
components of ancestry.
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Summary results for Hispanics from each study were combined for an inverse variance
weighted fixed-effectsmeta-analysis of Hispanics only. Similarly, all African American results
were combined for an inverse variance weighted fixed-effectsmeta-analysis of African Ameri-
cans. Results from these race-specificmeta-analyses are presented. We then conducted trans-
ethnic meta-analyses of African Americans and Hispanics by combining all study-specificAfri-
can American and Hispanic summary results from PAGE and the FBPP using (1) a fixed
effects and (2) a random-effects approach described by Han and Eskin [27] as implemented in
their software, METASOFT (http://genetics.cs.ucla.edu/meta). Between study/race-ethnicity
effect sizes consistency was assessed using the Q test (Chi-squared p-value) and the I2 metric,
where low I2 suggests little between-study/race-ethnicity variability. For the meta-analyses, we
filtered out SNPs with a minor allele frequency less than 0.01. Results for all analyses were
reported as Betas and standard errors (SE).
We sought to replicate our main findings from the discoverymeta-analyses in MESAHis-
panics and African Americans with the same protocols used in the discovery analysis (see
Methods A in S1 File), and validated our findings in European ancestry samples using publi-
cally available ICBP data. A conservative SNP discovery significance threshold for the Metabo-
chip array, P< 2.8 x 10−7 was used to account for the numbers of tests performed in the
discovery analyses.
For our replication of previously reportedGWAS SNPs (identifiedmainly in populations of
European ancestry) in our multi-ethnic population, we defined nominally significant as
‘p<0.05 and not corrected for multiple testing.’
Given the different recruitment and BP measurement in the Mt. Sinai BioMe sample, we
performed a sensitivity analysis excluding the study from the Hispanic meta-analysis, and
reviewed findings for consistency with the total Hispanic results. In a secondary analysis, we
measured associations between hypertension and selected BP-associated SNPs using logistic
regression models and reported odds ratios (OR) and 95% confidence intervals (95%CI).
We also fine-mapped 22 published BP loci previously identified in European and East Asian
ancestry populations that were available on the Metabochip [Tables D-E in S1 File]. For these
analyses, we focused on the African ancestry samples as this population, on average, has greater
haplotype diversity and shorter LD blocks compared to Hispanics [28, 29]. In other words, a
given SNP in a genomic locus of interest will typically have fewer numbers of SNPs highly cor-
related with it in African Americans, making it somewhat easier to reduce the size of a genomic
locus of interest, and thus the number of potential causal SNP(s). To investigate SNPs in each
BP-associated locus, we assessed whether the most significant SNP at each locus in African
Americans was distinct from, but correlated (r2 0.50) with the index (i.e. previously reported
GWAS) SNP based on LD information from the 1000 Genomes Project (1000G) European
ancestry populations (EUR). Using Locus Zoomplots, we also plotted other candidate func-
tional variants in the region. The fine-mapping significance threshold was set at the Bonfer-
roni-corrected threshold of P<0.05/number of Metabochip SNPs at each locus. Other LD
estimates in the 1000G populations were obtained using the LDlink tool [30].
Results
A total of 19,706 Hispanic individuals from three studies and 18,744 AfricanAmerican individ-
uals from five studies contributed to the analyses (Table 1).
Discovery and replication in Hispanics
In the discovery analysis, querying all SNPs on the Metabochip, there was little evidence for
inflation due to population stratification in the Hispanic samples (Figure A in S1 File). Meta-
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analyses of the Hispanic studies identified 14 SNPs in three loci significantly associated with
either systolic BP or diastolic BP (Table 2, and Tables A-B in S1 File). These SNPs were all in
known BP loci rather than in Metabochip loci linked with other cardiometabolic traits. The
most significant SNP (rs2586886/G) located in intron 1 of potassium channel, subfamily K,
member 3 (KCNK3) on chromosome 12 was associated with a 0.72 mmHg increase in diastolic
BP (P = 5.2 x 10−9) (Table 2). This SNP was also associated with increased systolic BP (P = 3.8
x 10−4), and a 13% increased odds of hypertension (OR = 1.13; 95%CI: 1.06–1.22; P = 4.0 x
10−4) in 5822 hypertension cases and 13,477 controls. Other SNPs associated with BP in His-
panics were located at two previously established loci, FGF5 (chromosome 4) and ATXN2-
SH2B3 (chromosome 12) (Tables A-B, and Figure B in S1 File). At FGF5, conditional analyses
of the most significant SNP, rs1458038, which is also reported in individuals of European
ancestry [31], supported the evidence for a single association at the locus (Table A in S1 File).
At the ATXN2-SH2B3 locus, the most significant SNP rs11065979 was in LD with a missense
Table 1. Descriptive characteristicsa of the PAGE and FBBP studies by race/ethnicity.
Sample Study Total N Female, % Age, years BMI, kg/m2 DBP, mmHgb SBP, mmHgb HTN Meds, % HTN,%
Hispanics
WHI 5,155 100% 60 (7) 29 (6) 76 (10) 128 (19) 21% 38%
HCHS/SOL 11,653 58% 47 (13) 30 (6) 75 (11) 125 (19) 17% 28%
Mt. Sinai BioMe 2,898 65% 49 (15) 29 (7) 74 (11) 123 (18) 28% 38%
African Americans
ARIC 3,340 63% 54 (6) 30 (6) 82 (13) 133 (23) 41% 55%
CARDIA 1,797 58% 24 (4) 26 (6) 69 (10) 112 (11) 1% 1%
WHI 11,800 100% 62 (7) 31 (7) 81 (10) 137 (20) 48% 61%
HyperGEN
Cases 947 68% (68%) 51 (11) 33 (7) 76 (12) 135 (23) 92% 92%
Controls 298 63% (63%) 35 (10) 31 (8) 70 (8) 116 (12) 0% 0%
GenNet
Cases 153 54% 41 (7) 34 (10) 89 (14) 143 (18) 53% 53%
Controls 409 49% 35 (9) 29 (8) 71 (10) 117 (13) 0% 0%
N, number; BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure; HTN, hypertension; Meds, medications
aResults presented as mean (standard deviation)
bSummaries based on BP values before correction for hypertension medication use
doi:10.1371/journal.pone.0164132.t001
Table 2. Main findingsa for meta-analysis of diastolic and systolic BP in PAGE Hispanic samples (n~19,706).
SNP Chr Gene Locus Coded/ other allele Coded allele frequency Beta (SE) P-value
Diastolic BP
rs2586886 2 KCNK3 G/A 0.32 0.72(0.12) 5.2 x 10−9
rs1458038 4 FGF5 A/G 0.23 0.71(0.13) 1.2 x 10−7
rs11065979b 12 SH2B3-ATXN2 A/G 0.27 -0.73(0.13) 2.5 x 10−8
rs11066188b 12 HECTD4 A/G 0.26 0.70(0.13) 1.3 x 10−7
Systolic BP
rs1458038 4 FGF5 A/G 0.23 1.37(0.22) 8.6 x 10−10
Chr, chromosome; SE, standard error
aOnly the lowest p-value SNPs for each locus are shown.
bThese SNPs are in linkage disequilibrium (r2 = 0.84 and D’ = 0.98) in the 1000G AMR population
doi:10.1371/journal.pone.0164132.t002
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variant rs3184504 (minor allele frequency = 0.28, P = 1. 4 x 10−7, r2 = 0.91) (Table B and
Figure B in S1 File) [9]. A nearby intronic SNP inHECTD4 (rs11066188) also reached array-
wide significance (P = 1.3 x 10−7) and was in LD with the aforementioned ATXN2-SH2B3 vari-
ants (r2 = 0.74–0.84 in 1000G AMR).
The rs2586886/KCNK3 SNP replicated in independent Hispanic samples fromMESA for
diastolic BP (P = 0.02, β = 0.78) (Table 3). This SNP is also significantly associated with systolic
and diastolic BP in the European ancestry GWAS meta-analysis from the ICBP, and with sys-
tolic BP in AfricanAmericans, but was borderline significant for diastolic BP in African Ameri-
cans (Table 2).
In sensitivity analyses excluding Mt. Sinai BioMe, rs2586886/KCNK3 remained significantly
associated with diastolic BP, P = 3.1 x 10−9. P-values for other diastolic and systolic SNPs
increased to values above the significance threshold, P = 2.8 x 10−7. However, none of the SNPs
showed evidence of heterogeneity by study in the meta-analysis of all Hispanics includingMt.
Sinai, all heterogeneity P>0.4 and I2~0. Using PAGE Hispanic results, we performed a look-up
of previously identifiedGWAS SNPs in 22 loci (Table C in S1 File). GWAS SNPs from 15 loci
replicated in Hispanics at p<0.05.
Replication, fine mapping and discovery in African Americans
We first attempted to replicate the 22 BP loci previously identified in GWAS of BP in European
ancestries using African American samples. These meta-analyses identified SNPs in FGF5,
ATP2B1, TBX3 and LOC339593nominally associated with systolic BP (Table D in S1 File), and
SNPs in FGF5, SLC39A8,ARHGAP42,ADM, CPLX3, LOC339593 and ZNF831 nominally asso-
ciated with diastolic BP, all P<0.05 (Table E in S1 File). To fully capture the European-ances-
try GWAS SNP ‘signal’, we then extended the association analyses in African Americans to
include all SNPs in modest LD (r20.5 in 1000G EUR) with each reported GWAS SNP. These
analyses identified additional associations in African Americans atMTHFR, EBF1,C10orf107,
CYP17A1,NT5C2,CSK, and PLCD3 for either diastolic or systolic BP with P-values ranging
from 6.9 x 10−5 to 0.04, (Tables D-E in S1 File).
Rs56153133/CLCN6was significantly associated with diastolic BP (P = 6.9 x 10−5) at the
locus-level significance threshold (P<1.4 x 10−4) in African Americans (Figure C in S1 File).
This SNP is in high LD (r2 = 0.98 in 1000G EUR) with the previously reported GWAS SNP
rs17367504 in theMTHFR locus. However, rs17367504/MTHFRwas not associated with dia-
stolic BP in African Americans (P = 0.24), in spite of its relatively high correlation with
rs56153133 (r2 = 0.65 in PAGE African Americans). In a model conditioning on rs17367504,
rs56153133 remained significantly associated with diastolic BP, P = 1.3x10-6, providing evi-
dence to support its independence from rs17367504. However, the rs56153133-diastolic BP
association did not replicate in the independent, though smaller (n = 2550) MESA African
American sample, P = 0.88.
Table 3. Validation of the KCNK3 rs2586886 associations with BP in independent multi-ethnic populations.
Study-race BP Trait Coded allele Coded allele frequency Beta(SE) P value Total N
MESA-Hispanics Diastolic G 0.30 0.94(0.37) 0.01 2,108
ICBP-whites Diastolic NA 0.33 NA 0.02 69,395
Systolic NA 0.33 NA 1.9 x 10−3
PAGE & FBBP- Diastolic G 0.45 0.23(0.11) 0.04 18,744
African Americans Systolic G 0.45 0.42(0.18) 0.02
BP, blood pressure; N, number; SE, standard error; ICBP, International Consortium of Blood Pressure; NA, not available in publicly available data
doi:10.1371/journal.pone.0164132.t003
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The strongest associations in the systolic BP fine mapping were located in the 15q26.1 locus
(FURIN), but none of the SNPs reached the fine-mapping significance threshold for the locus
(P<5 x 10−4). The most significant (P = 8.0 x 10−4) SNP in this locus in African Americans is
rs6224, an intronic variant in FURIN. Rs6224/FURIN, is in low LD (r2 = 0.08) in AfricanAmer-
icans with the prior GWAS SNP in this region, rs2521501/FES, and in modest LD (r2 = 0.46)
with it in the 1000G EUR (Figure D in S1 File).
In a full Metabochip scan testing for new SNP associations with BP traits in African Ameri-
cans, no SNPs reached the discovery (multiple testing-adjusted) significance threshold (P<2.8
x 10−7).
Trans-ethnic meta-analyses
To increase power to identify associations in the discovery scan, we also performed trans-eth-
nic meta-analyses by combining results fromHispanics and African Americans.We used two
approaches for the meta-analyses: a fixed-effectsmodel, and a random-effectsmodel optimized
to detect associations under heterogeneity, as implemented in MetaSoft [27]. While no novel
loci were identified, there were eight array-wide significant (P<2.8 x 10−7) SNPs inULK4, and
two SNPs in 5`region of FGF5 associated with diastolic BP (Table F in S1 File).
Several SNPs were also significantly associated with systolic BP including rs2023843, a
novel intronic SNP inHOTTIP (in theHOXA-EVX1 locus) (Figure E in S1 File). This SNP rep-
licated in MESAHispanics, P = 0.038 and was borderline significant in MESA African Ameri-
cans, P = 0.064. Rs2023843 is in modest LD (r2 = 0.27 in 1000G AFR) with rs11564022/
HOXA-EVX1 previously reported in African Americans (and not available on the Metabo-
chip), though LD with it in 1000G AMRHispanics is very low (r2 = 0.03). SNPs upstream of
FGF5were also significantly associated with systolic BP in the trans-ethnic analysis, and most
appear to be mainly driven by the Hispanic American results. The most significant trans-ethnic
SNP at the FGF5 locus, rs13125101 is in high LD (r2>0.8 in CEU) with the prior GWAS SNPs
(rs16998073 and rs11099098) suggesting that it may reflect the same signal (Figure F in S1
File).While this locus is not novel, we identified a significant FGF5 intronic SNP not previously
associated with BP, rs36034102. However this SNP was not associated with systolic BP
(P = 0.25) in the smaller sample of MESAHispanics (n = 2106) although the direction and
magnitude of the beta coefficientwere similar, β = 0.89 in MESA, β = 1.05 in PAGE (data not
shown).
All SNPs significant in the fixed-effects trans-ethnic meta-analyses were also significant
when using the Han and Eskin (HE) random-effectsmeta-analysis models with the exception
of one systolic BP SNP (rs72656599/5’ of FGF5), which was borderline significant in the ran-
dom-effectsmodel. As expected,P-values for the two models were generally comparable, with
fixed effectsmodels having lower P-values, except in the presence of high heterogeneity (I2
80) between the race/ethnicity groups. In cases of high heterogeneity, the HE random-effects
P-values were lower than those from fixed effectsmodels.
Discussion
We describe the replication of several BP loci in two lesser studied populations, US Hispanics
and African Americans and also report novel SNPs associations in these previously published
loci. In Hispanics, we identified 14 variants in known loci associated with blood pressure,
including an intronic variant in KCNK3 associated with diastolic BP. In trans-ethnic analyses,
we also identified a variant inHOTTIP associated with systolic BP. Both of these variants repli-
cated in an independent sample of Hispanics.
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In addition to diastolic BP, the KCNK3 intronic SNP was also significantly associated with
systolic BP and associations replicated in European and African ancestry samples. Each copy
of the KCNK3 rs2586886-G allele was associated with 13% increased odds of hypertension in
Hispanics. KCNK3 encodes TASK-1, a member of the superfamily of potassium channel pro-
teins, which functions primarily to control the resting membrane potential in many cell types.
KCNK3 has been previously associated with mean arterial pressure and systolic blood pressure
in GWAS of individuals of European and East Asian ancestry, and more recently in candidate
gene analyses of African Americans and Hispanics [32–34]. The previously reported associa-
tion is for a SNP located at 2kb upstream of KCNK3 (rs1275988) [32, 33], which is in LD with
rs2586886 in our Hispanic sample (r2 = 0.70) and in 1000G EUR (r2 = 0.94), and thus likely
represent the same association. Using 1000G AMR haplotypes, two SNPs (rs12476527/pro-
moter and rs12775923/first intron) fall within putative regulatory elements that serve as bind-
ing sites for transcription factors and impact transcription factor binding in relevant tissues,
suggesting a possible mechanism for the BP association at this locus (Table G in S1 File shows
sources). Both of these SNPs are in strong LD with our identified SNP rs2586886, with r2 =
0.69 and 0.79, respectively, in the 1000G AMR population. The observation that rs1275988 is
enrichedwith DNA methylation sites lends further support to the notion that regulatory path-
ways contribute to BP variation [33].
KCNK3 protein TASK-1 is highly expressed in the human adrenal cortex in the aldoste-
rone-synthesizing layer, the zona glomerulosa, that regulates aldosterone secretion [35].
Female TASK1-/- mice lackingKCNK3 develop hypokalemia and low-renin hypertension that
is normalized by mineralocorticoidreceptor blockade but controlled by ACTH, a consequence
of misallocation of aldosterone synthase in the zona fasciculate [36]. TASK-1 (kcnk3) and
TASK-3 (kcnk9) double-knockoutmice (TASK-1-/-/TASK-3-/-) recapitulate the key features of
human primary hyperaldosteronism [37], the most common cause of endocrine hypertension.
Specifically, they have elevated aldosterone production despite low plasma renin, and increased
aldosterone levels on low-sodiumdiets that is not normalized by angiotensin-2 receptor block-
ade, nor suppressed by a high sodium loading. Our KCNK3 SNP, rs2586886, has been recently
shown to associate with aldosterone levels by our collaborators, although findings did not repli-
cate in an independent sample and may be confounded by use of medications that suppress
aldosterone[34]. Overall, our findings that the common KCNK3 variant is associated with
hypertension in Hispanics suggest that further work is needed to explore hypertension related
salt-sensitivity in this population. These findingsmay also have clinical implications regarding
the choice of medications for hypertension treatment in this population, which should be
explored in future studies.
We replicated several GWAS loci in our population, but not necessarily the previously
reportedGWAS SNPs. These include the FGF5 and ATXN2- SH2B3 loci in Hispanics and
CLCN6/MTHFR locus in AfricanAmericans. In total, 16 of the 22 BP loci tested nominally rep-
licated in African Americans and GWAS SNPs in 15 of 22 loci nominally replicated in Hispan-
ics. Fine-mapping of the CLCN6/MTHFR and FES/FURIN loci identified potential causal
variants, though these findings should be interpreted cautiously given their lack of robust repli-
cation and/or modest P-values.
Although the trans-ethnic meta-analysis did not reveal new BP loci, we did identify novel
SNPs not previously associated with BP traits in loci identified in European-ancestry individu-
als, including the FGF5 [8],ULK4 [38] and theHOXA-EVX1 loci. SNP rs2023843 is an intronic
variant ofHOTTIP at theHOXA-EVX1 locus. Three SNPs in this locus associated with BP
traits (rs17428471, rs17471520, and rs11564022) were recently identified in individuals of Afri-
can ancestry [15] (including a subset of our population). LD between rs2023843/HOTTIP and
these variants is very low (r2<0.05) in Hispanics and African American 1000G populations
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with the exception of rs11564022, in which r2 = 0.27 in African Americans. Rs11564022 was
not available in large numbers of our sample, so were unable to test the independence of the
HOTTIP association.
In general, we observed less significant findings when the Mt. Sinai BioMe sample (~15% of
the total sample) was excluded from analyses in Hispanics. Discordance between clinic mea-
surements, such as those obtained in the Mt.Sinai BioMe sample, and research BP measure-
ments has been reported to either under- or overestimate BP [39], potentially increasing
measurement error and reducing power for SNP associations. Notably, the rs2586886/KCNK3
association in Hispanics was more robust after exclusion of the Mt.Sinai BioMe sample. An
additional key limitation of our study was that fine-mapping could only be performed in Meta-
bochip regions with high density genotyping. For example, we were unable to fine-map the
ULK4 orHOTTIP (HOXA-EVX) loci due to low density genotyping in these regions on the
Metabochip. Furthermore, BP loci for replication and novel SNPs for discoverywere limited to
SNPs available on the Metabochip array.
In summary, in this first large array scan of BP traits in Hispanics, we identifiedKCNK3 and
HOTTIP (HOXA-EVX1) as important loci associated with BP variation in Hispanics and Afri-
can American populations, respectively. We also replicated several BP loci identified in individ-
uals of European ancestry in both Hispanics and African Americans supporting the
importance of many common BP genetic loci across diverse populations. Our work demon-
strates how studying genetically diverse populations may reveal novel genetic variants that can
be used to better refine the location of causal variant(s), and inform research of potential drug
targets in affected populations.
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